Preimplantation Genetic Testing Market: Global Industry Analysis by Size, Share, Growth, Sourcing Strategy, Scope, Demand and Forecast to 2034
Emergen Research presents an in-depth analysis of the Global Preimplantation Genetic Testing Market, offering a detailed understanding of industry trends, growth patterns, and future opportunities. By considering historical data from earlier years and using 2019 as the base year, the study delivers a clear and structured outlook of how the Preimplantation Genetic Testing market is expected to evolve.
The research content has been designed to assist investors, stakeholders, and business strategists in making informed decisions. It provides strategic recommendations that enable organizations to maximize returns on their investments while identifying new avenues for growth. The study carefully evaluates both established players and emerging participants in the market, helping businesses understand the competitive positioning and future potential of different companies.
Preimplantation Genetic Testing Market Size and Overview
The preimplantation genetic testing market is expected to grow from an estimated USD 0.8 billion in 2024 to USD 2.2 billion in 2033, at a CAGR of 11.90%.
The global preimplantation genetic testing market size is expected to grow from 0.8 billion by the end of 2024 to 2.2 billion by 2033, registering a revenue CAGR of 11.90% during the forecast period. Preimplantation genetic testing (PGT) is gaining significant attention within the global assisted reproductive technologies (ART) industry.
The advancement in PGT methods is driving better outcomes for families experiencing infertility, as it allows the identification of genetic conditions in embryos prior to implantation. According to the American Society for Reproductive Medicine (ASRM), the prevalence of genetic disorders, including aneuploidy and single gene disorders, has spurred the growth of the PGT market. Additionally, PGT procedures enable the selection of healthy embryos for implantation, which enhances pregnancy rates and reduces the risk of genetic diseases.
Furthermore, the increasing use of advanced technologies like next-generation sequencing (NGS) and fluorescence in situ hybridization (FISH) is contributing to the robust market growth. The market is further being propelled by rising awareness of genetic screening among patients and the availability of improved treatment options through fertility clinics and diagnostic laboratories.
Market trends indicate a growing preference for non-invasive methods and improved genetic testing solutions. For instance, a report by the International Society for Prenatal Diagnosis (ISPD) noted that over 15 million genetic testing procedures were conducted globally in 2023, showcasing the expanding need for genetic screening in reproductive health. This market expansion is also supported by technological innovations, such as single-nucleotide polymorphism (SNP) testing and advances in genomic analysis, which allow for more precise and reliable genetic profiling.
A key feature of the report is its ability to address critical business questions that directly impact market strategies. It explores which segments are expected to demonstrate strong growth, how consumer demand is likely to shift, and what macroeconomic and microeconomic factors are influencing the market. Additionally, it provides insights into the role of technological advancements and research and development activities in shaping the future of the Preimplantation Genetic Testing market.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @
https://www.emergenresearch.com/request-free-sample/4006
Preimplantation Genetic Testing Market: Global Industry Analysis by Size, Share, Growth, Sourcing Strategy, Scope, Demand and Forecast to 2034
Emergen Research presents an in-depth analysis of the Global Preimplantation Genetic Testing Market, offering a detailed understanding of industry trends, growth patterns, and future opportunities. By considering historical data from earlier years and using 2019 as the base year, the study delivers a clear and structured outlook of how the Preimplantation Genetic Testing market is expected to evolve.
The research content has been designed to assist investors, stakeholders, and business strategists in making informed decisions. It provides strategic recommendations that enable organizations to maximize returns on their investments while identifying new avenues for growth. The study carefully evaluates both established players and emerging participants in the market, helping businesses understand the competitive positioning and future potential of different companies.
Preimplantation Genetic Testing Market Size and Overview
The preimplantation genetic testing market is expected to grow from an estimated USD 0.8 billion in 2024 to USD 2.2 billion in 2033, at a CAGR of 11.90%.
The global preimplantation genetic testing market size is expected to grow from 0.8 billion by the end of 2024 to 2.2 billion by 2033, registering a revenue CAGR of 11.90% during the forecast period. Preimplantation genetic testing (PGT) is gaining significant attention within the global assisted reproductive technologies (ART) industry.
The advancement in PGT methods is driving better outcomes for families experiencing infertility, as it allows the identification of genetic conditions in embryos prior to implantation. According to the American Society for Reproductive Medicine (ASRM), the prevalence of genetic disorders, including aneuploidy and single gene disorders, has spurred the growth of the PGT market. Additionally, PGT procedures enable the selection of healthy embryos for implantation, which enhances pregnancy rates and reduces the risk of genetic diseases.
Furthermore, the increasing use of advanced technologies like next-generation sequencing (NGS) and fluorescence in situ hybridization (FISH) is contributing to the robust market growth. The market is further being propelled by rising awareness of genetic screening among patients and the availability of improved treatment options through fertility clinics and diagnostic laboratories.
Market trends indicate a growing preference for non-invasive methods and improved genetic testing solutions. For instance, a report by the International Society for Prenatal Diagnosis (ISPD) noted that over 15 million genetic testing procedures were conducted globally in 2023, showcasing the expanding need for genetic screening in reproductive health. This market expansion is also supported by technological innovations, such as single-nucleotide polymorphism (SNP) testing and advances in genomic analysis, which allow for more precise and reliable genetic profiling.
A key feature of the report is its ability to address critical business questions that directly impact market strategies. It explores which segments are expected to demonstrate strong growth, how consumer demand is likely to shift, and what macroeconomic and microeconomic factors are influencing the market. Additionally, it provides insights into the role of technological advancements and research and development activities in shaping the future of the Preimplantation Genetic Testing market.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-free-sample/4006
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek